Skip to content
Luna Metabolic
Menu

Head-to-head for women

REMEVi vs CoreAge Rx

REMEVi and CoreAge Rx both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

REMEVi

Ranked #17 for women · Grade B

Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.

Visit REMEVi
vs

CoreAge Rx

Higher score

Ranked #1 for women · Grade A

Best for: Women who want transparent flat pricing and dependable nationwide access to both semaglutide and tirzepatide, without a teaser-rate bait-and-switch.

Visit CoreAge Rx

The verdict for women

Higher Luna Fit Score: CoreAge Rx

CoreAge Rx edges out REMEVi on the Luna Fit Score, 93 to 85 (A vs B). Women who want transparent flat pricing and dependable nationwide access to both semaglutide and tirzepatide, without a teaser-rate bait-and-switch.

REMEVi is still a genuine option — an accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end. Weigh the six women's-health factors below against your own priorities.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

REMEVi CoreAge Rx
PCOS & hormonal suitability8390
REMEVi
CoreAge
Clinical oversight & labs8588
REMEVi
CoreAge
Price transparency8297
REMEVi
CoreAge
Nationwide access9596
REMEVi
CoreAge
Ongoing support8392
REMEVi
CoreAge
Cancellation fairness8295
REMEVi
CoreAge

Price, access & features

DetailREMEViCoreAge Rx
Luna Fit Score85/100 · B93/100 · A
Overall rank#17#1
Semaglutide$199/mo$149/mo
Tirzepatide$269/mo$349/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

REMEVi

Ranked #17 · Grade B

What we like

  • LegitScript-accredited and available in all 50 states
  • Both molecules disclosed, tirzepatide for insulin-resistant PCOS
  • Clear, predictable pricing

The caveats

  • Higher-end pricing — $199 semaglutide, $269 tirzepatide
  • No oral or brand-name option; general program without hormone specialization

CoreAge Rx

Ranked #1 · Grade A

What we like

  • Both compounded semaglutide and tirzepatide on one account — tirzepatide is often preferred where insulin resistance drives PCOS weight
  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Available in all 50 states — no coverage gaps if you move or travel

The caveats

  • Not the rock-bottom price — budget shoppers can find cheaper teaser tiers elsewhere
  • No FDA-approved brand-name option (compounded only)
  • General metabolic program rather than a dedicated hormone/PCOS clinic

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Luna Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing REMEVi and CoreAge Rx against other providers we review for women.

Or browse the full comparison hub.